Results 51 to 60 of about 9,378,676 (283)

Recommendations for the use of meningococcal vaccines in South Africa

open access: yesSouthern African Journal of Infectious Diseases, 2017
Background: Although meningococcal disease (MD) incidence in South Africa is low, Neisseria meningitidis (NM) causes severe disease that is often life-threatening and can cause long-term disabilities.
Susan Meiring   +4 more
doaj   +1 more source

Meningococcal vaccines in China

open access: yesHuman Vaccines & Immunotherapeutics, 2021
Meningococcal meningitis caused by Neisseria meningitidis is a reportable infectious disease in China, due to the high incidence of meningitis in the era before the availability of vaccines.
Yinghua Xu   +5 more
doaj   +1 more source

Editorial: Meningococcal disease

open access: yesCommunicable Diseases Intelligence, 2001
This article published in Communicable Diseases Intelligence Volume 25, No 3, August 2001 contains an editorial on meningococcal disease.
P, Roche, J, Spencer, A, Marianos
openaire   +2 more sources

Invasive meningococcal disease and travel

open access: yesJournal of Infection and Public Health, 2010
Summary: The epidemiology of invasive meningococcal disease varies geographically and in time and the risk of acquiring the disease varies regionally, as well as with living conditions and behavior.
Ziad A. Memish   +4 more
doaj   +1 more source

The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations

open access: yesExpert Review of Vaccines, 2018
Introduction: The 2018 Global Meningococcal Initiative (GMI) meeting focused on evolving invasive meningococcal disease (IMD) epidemiology, surveillance, and protection strategies worldwide, with emphasis on emerging antibiotic resistance and protection ...
R. Acevedo   +25 more
semanticscholar   +1 more source

Clinical Case of Repeated Generalized Infection and Meningitis in Immunocompetent Child

open access: yesПедиатрическая фармакология, 2021
Background. Meningococcal disease is socially significant, deadly infectious disease characterized by severe and unpredictable course. Clinical case description.
Mariya S. Vedyashkina   +3 more
doaj   +1 more source

Pericarditis due to Neisseria meningitidis serogroup W135

open access: yesIDCases, 2018
Neisseria meningitidis is a well-recognized cause of bacterial meningitis. Although less common, N. meningitidis can also involve extra-meningeal sites, including the pericardium.
Takashi Shinha, Hiroshi Fujita
doaj   +1 more source

Factors Affecting Immune Reconstitution Post‐Allogeneic HSCT in Children: The Case for an Individualized Approach to Vaccination

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Allogeneic hematopoietic stem cell transplantation (HSCT) is increasingly used to treat malignant and non‐malignant diseases. Following allogeneic HSCT, patients are particularly vulnerable to vaccine‐preventable diseases (VPD) because conditioning depletes immune cells, including memory cells.
Hélène Buvelot   +3 more
wiley   +1 more source

Risk and protective factors for meningococcal disease in adolescents: matched cohort study [PDF]

open access: yes, 2006
Objective: To examine biological and social risk factors for meningococcal disease in adolescents. Design: Prospective, population based, matched cohort study with controls matched for age and sex in 1:1 matching.
Booth, C.   +9 more
core  

The association between life events, social support, and antibody status following thymus-dependent and thymus-independent vaccinations in healthy young adults [PDF]

open access: yes, 2005
This study determined whether stressful life events and social support were related to antibody status following both thymus-dependent and thymus-independent vaccinations. Life events in the previous year and customary social support were measured in 57
Burns, Victoria E.   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy